Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China

Completed · Phase 3

Conditions studied: Opiate Dependence, HIV Infections

In brief

A randomized clinical trial evaluating the reduction of HIV risk behaviors and drug use when providing integrated behavioral drug and HIV risk reduction counseling (BDRC) along with methadone maintenance treatment in Wuhan, China

Key facts

Study ID

NCT00757744

Run by

Yale University

People needed

45

Starts

2007-09-01

Expected to finish

2010-09-01

Last updated by the study team

2020-03-30

Who can join

Age: 20 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• opioid dependence

You may not qualify if…

• current dependence on alcohol, benzodiazepines or sedatives
• current suicide or homicide risk
• current psychotic disorder or untreated major depression
• life-threatening or unstable medical problems

Where it is running

• Yale University School of Medicine - CMHC — New Haven, Connecticut, United States
• Wuhan Center for Disease Control and Prevention — Wuhan, Hubei, China

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.